8-K
filed November 3, 2023, 7:59 PM ET
ticker ACH
CIK 0000075252
earnings
confidence high
sentiment neutral
materiality 0.65
Owens & Minor Q3 revenue up 3.8% to $2.59B; adjusted EPS $0.44, debt cut $188M
ACCENDRA HEALTH INC/VA/
2023-Q3 EPS reported
-$0.78
revenue$7,677,817,000
- Revenue $2.59B vs $2.497B in Q3 2022, driven by Patient Direct and Medical Distribution growth.
- GAAP net loss per share $(0.08); adjusted net income per share $0.44.
- Total debt paydown of $188M; net debt reduced by $117M.
- Patient Direct outperformed market; Medical Distribution posted mid-single digit growth.
- Operating Model Realignment Program delivered economic benefits; cautious on long-term PPE trajectory.
Key facts
Extracted from this filing and checked against the source text.
Earnings Releases
SEC 8-K Item 2.02
confidence 0.7
ACCENDRA HEALTH INC/VA/ reported nine months ended September 30, 2023 results: revenue $7,678.
- Period
- nine months ended September 30, 2023
- Revenue
- $7,678
- Result
- reported results
Exact text from the filing
YTD YTD ($ in millions, except per share data) 3Q23 3Q22 2023 2022 Revenue $2,592 $2,497 $7,678 $7,404 Operating income, GAAP $23.8 $60.2 $44.5 $196.4
View on SEC.gov
Earnings Releases
SEC 8-K Item 2.02
confidence 0.9
ACCENDRA HEALTH INC/VA/ reported third quarter ended September 30, 2023 results: revenue $2.59 billion, net income Net loss per common share of $(0.08), EPS $(0.08).
- Period
- third quarter ended September 30, 2023
- Revenue
- $2.59 billion
- Net income
- Net loss per common share of $(0.08)
- EPS
- $(0.08)
- Result
- reported results
Exact text from the filing
2023 – Owens & Minor, Inc. (NYSE: OMI) today reported financial results for the third quarter ended September 30, 2023. Third Quarter Key Highlights: • Consolidated revenue of $2.59 billion • Net loss per common share of $(0.08) and adjusted net income per common share of $0.44 • $188 million in total debt pay down and $117 million reduction in net debt “Our
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.